AGIO(Agios Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $0 | $14.24M | $26.82M | $36.50M | $54.03M |
| 毛利润 | $0 | $12.54M | $23.94M | $32.33M | $47.68M |
| 营业利润 | −$378.42M | −$389.05M | −$391.49M | −$425.74M | −$472.13M |
| 净利润 | $1.60B | −$231.80M | −$352.09M | $673.73M | −$412.78M |
| 经营现金流 | −$407.32M | −$309.48M | −$296.06M | −$389.84M | −$372.98M |
| 自由现金流 | −$413.06M | −$314.36M | −$297.06M | −$391.53M | −$377.29M |
| 摊薄每股收益 | $26.55 | $-4.23 | $-6.33 | $11.64 | $-7.12 |